Fasudil (Actelion)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameFasudil (Actelion)
Drug Alias NamefasudilFasudil (CoTherix)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated kinases inhibitors
TargetsRho-associated kinases
Therapy Area/IndicationsHypertension, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorth AmericaWestern Europe
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAsahi Kasei Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCotherix IncActelion Ltd
Active IndicationsN/A
Inactive IndicationsHypertension, Pulmonary

Other Information

ATC CodeN/A
Related LinksN/A